Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues. | Hypertens Res | 2024 | 38778172 | PubTator, text mining | PubMed |
| AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia. | Theranostics | 2024 | 38773967 | PubTator, text mining | PubMed |
| Gas6/TAM system as potential biomarker for multiple sclerosis prognosis. | Front Immunol | 2024 | 38745659 | PubTator, text mining | PubMed |
| Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer. | iScience | 2024 | 38726365 | PubTator, text mining | PubMed |
| Immunological role of Gas6/TAM signaling in hemostasis and thrombosis. | Thromb Res | 2024 | 38723521 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and ATAC sequencing identify novel biomarkers for bicuspid aortic valve-associated thoracic aortic aneurysm. | Front Cardiovasc Med | 2024 | 38685981 | PubTator, text mining | PubMed |
| Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling. | Cancer Lett | 2024 | 38677641 | PubTator, text mining | PubMed |
| Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing. | Int J Mol Sci | 2024 | 38673989 | PubTator, text mining | PubMed |
| Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 38673795 | PubTator, text mining | PubMed |
| Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease. | Indian J Ophthalmol | 2024 | 38648454 | PubTator, text mining | PubMed |
| The Role of Hepatic Stellate Cells and the Gas6/Axl Axis in Liver Fibrosis and Hepatocellular Carcinoma. | J Clin Exp Hepatol | 2024 | 38601748 | PubTator, text mining | PubMed |
| Correction to: Gas6 Promotes Microglia Efferocytosis and Suppresses Inflammation Through Activating Axl/Rac1 Signaling in Subarachnoid Hemorrhage Mice. | Transl Stroke Res | 2024 | 38584209 | PubTator, text mining | PubMed |
| Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily. | Clin Immunol | 2024 | 38575045 | PubTator, text mining | PubMed |
| The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3. | Glia | 2024 | 38572807 | PubTator, text mining | PubMed |
| In Situ Nanofiber Formation Blocks AXL and GAS6 Binding to Suppress Ovarian Cancer Development. | Adv Mater | 2024 | 38546279 | PubTator, text mining | PubMed |
| The TAM Subfamily of Receptor Tyrosine Kinases: The Early Years. | Int J Mol Sci | 2024 | 38542343 | PubTator, text mining | PubMed |
| LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3. | Cancer Lett | 2024 | 38521199 | PubTator, text mining | PubMed |
| Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC. | J Cell Mol Med | 2024 | 38501838 | PubTator, text mining | PubMed |
| Pterostilbene protects against H2 O2 -induced oxidative stress by regulating GAS6/Axl signaling in HL-1 cells. | Cell Biochem Funct | 2024 | 38403920 | PubTator, text mining | PubMed |
| Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study. | Diagnostics (Basel) | 2024 | 38396460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=12